Lifeway Foods, INC 8-K filings

Lifeway Foods announced record-breaking quarterly net sales of $66.9 million, marking the 27th consecutive quarter of year-over-year growth, despite facing temporary margin headwinds from elevated milk and packaging costs.

Lifeway Foods, Inc. has entered into a Master Security Agreement with CIBC Bank USA, establishing an interim funding facility of up to $22 million for equipment acquisition.

Lifeway Foods held its 2026 Annual Meeting of Shareholders, re-electing all board nominees and ratifying the appointment of Grant Thornton LLP as independent auditors.

Lifeway Foods, Inc. has officially redeemed all outstanding preferred share purchase rights, effectively terminating its shareholder rights agreement.

Lifeway Foods has supplemented its proxy statement to include Jason Scher as a director nominee for re-election, maintaining an eight-member board.

Lifeway Foods announced the pricing of a secondary underwritten public offering of 3,454,756 shares of common stock by Danone USA Public Benefit Corporation at $19.50 per share.

Lifeway Foods announced record-breaking first quarter results for 2026, with net sales reaching $63.0 million, a 37% increase driven by strong performance in Lifeway Kefir and Farmer Cheese.

Lifeway Foods, Inc. announced estimated unaudited net sales for the first quarter of 2026 are expected to increase by 32% to 35% year-over-year.

Lifeway Foods announced record-breaking full year 2025 net sales of $212.5 million and a 54% increase in net income, driven by strong demand for its kefir products.

Lifeway Foods, Inc. announced expected net sales for fiscal year 2025 to be between $211.0 and $212.5 million, projecting record-breaking revenue, and confirmed CEO Julie Smolyansky's participation in the ICR Conference.

Lifeway Foods' annual meeting saw the election of all management-nominated directors, but shareholders rejected proposed amendments to the company's articles of incorporation regarding director exculpation and indemnification.

Lifeway Foods, Inc. amended its credit agreement with CIBC Bank USA, extending the termination date to February 2029 and modifying financial covenants to support plant expansion.

Lifeway Foods, Inc. presented robust financial growth, strategic expansion plans, and new product innovations at its annual shareholders meeting on December 29, 2025.

Lifeway Foods, Inc. announced new board appointments and strongly refuted dissident director nominations, citing ethical concerns and financial distress of the nominees.

Lifeway Foods reported record Q3 2025 net sales of $57.1 million and significant net income growth, while also disclosing robust five-year financial projections.

Perfecto Sanchez has resigned from the Board of Directors of Lifeway Foods, Inc., effective immediately.

Lifeway Foods, Inc. announced the appointment of two new independent directors and an amendment to its bylaws to expand the board size.

Lifeway Foods' Board of Directors extended its Shareholder Rights Agreement for one year to protect against potential control acquisition without a premium.

Lifeway Foods, Inc. announced its 2025 annual meeting of shareholders will be held on December 16, 2025, with key deadlines for shareholder proposals.

Lifeway Foods, Inc. announced estimated unaudited net sales of $55.8 to $57.0 million for Q3 2025, marking a 21-24% increase year-over-year.

Jody Levy has resigned from the Board of Directors of Lifeway Foods, Inc., effective October 1, 2025, with no reported disagreements.

Lifeway Foods and Danone North America have signed a Cooperation Agreement to resolve ongoing litigation, refresh Lifeway's board, and establish future governance.

Lifeway Foods, Inc. announced record Q2 2025 net sales and continued Q3 momentum following Danone's withdrawal of its acquisition proposal.

Lifeway Foods announced estimated unaudited net sales of $39.1 million for the first two months of the third quarter, marking a 20% year-over-year increase.

Lifeway Foods announced record second-quarter 2025 net sales of $53.9 million, marking nearly six years of uninterrupted growth, and projects over 20% net sales growth for the third quarter to date.

Lifeway Foods announced that Institutional Shareholder Services Inc. (ISS) recommended shareholders not vote in connection with the ongoing dissident-led consent solicitation.

Lifeway Foods, Inc. announced a milestone achievement of surpassing $5.5 million in gross sales for the week ending July 13, 2025, marking a 66% increase from the prior year, and confirmed its second-quarter 2025 earnings release for August 12, 2025.

Lifeway Foods, Inc. has publicly rejected a consent solicitation filed by Edward and Ludmila Smolyansky, asserting it violates Illinois law and the company's organizational documents, while highlighting its significant shareholder returns and revenue growth.

Lifeway Foods, Inc. has entered into a definitive separation agreement with former executive Amy Feldman, providing a lump sum payment of $555,313.13 and vesting of 13,323 shares of common stock.

Lifeway Foods, a leading U.S. kefir supplier, announced significant net sales growth in early Q2 2025 and expanded distribution across major national retailers, driven by increasing consumer demand for probiotic-rich products.